Skip to main content
. 2021 Apr 6;42(5):832–842. doi: 10.1038/s41401-021-00648-x

Fig. 3. In vitro synergistic therapeutic study.

Fig. 3

a Cell inhibition rate and b IC50 values of ATO and PTX when combined as various formulations. c Combination index values of ATO and PTX in various formulations. d Cell cycle and e apoptosis analysis of MCF-7 cells treated with various formulations of ATO and PTX. f Western blotting analysis of apoptosis-related proteins in MCF-7 cells treated with ATO and PTX either alone or in combination.